2016 is the seventh year of China's health care reform, and medical innovation will usher in more opportunities. The attention of the capital market to the medical and health industry has played an important role in promoting the rapid development of the entire medical and health industry.
Recently, 84 medical and health-related enterprises are undergoing IPO audits, of which 42 have been accepted and 13 have been reported. The details are shown in the following figure. Among them, Zhuhai Jianfan Bio (July 22) issued an IPO listing.
From the subdivision field, there are 27 pharmaceuticals (18 chemical preparations, 9 Chinese patent medicines), 13 medical devices (excluding in vitro diagnostics), and 11 in vitro diagnostics (biochemical diagnosis 1 + immunodiagnosis 3 + molecular diagnosis 4 Home + POCT 2 + pathological diagnosis 1), 8 raw materials and intermediates, 6 biological products.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Sure enough, as scheduled, Zhuhai Jianfan Biotechnology Co., Ltd. officially listed on the GEM of the Shenzhen Stock Exchange yesterday. The stock is referred to as Jianfan Bio. The issue price is 10.80 yuan, and the listed opening price is 12.96 yuan. The closing price is closed at 15.55 yuan, the first day of listing rose by 43.98%.
Dehydrated jalapeno Pepper,Dehydrated jalapeno Green Pepper,Dehydrated jalapeno Red Pepper,Dehydrated jalapeno Pepper Powder
Xinghua Lvwei Foods Co.,Ltd , https://www.lvweifoods.com